Michaël Otto
- Microbiology top 0.01%
- Antimicrobial Peptides and Activities 81
- Infectious Diseases top 0.01%
- Antimicrobial Resistance in Staphylococcus 200
- HIV/AIDS drug development and treatment 53
- Clinical Biochemistry top 0.02%
- Bacterial Identification and Susceptibility Testing 29
- Molecular Medicine top 0.1%
- Molecular Biology top 0.05%
- Bacterial biofilms and quorum sensing 166
- Biochemical and Structural Characterization 60
-
- Hepatitis C virus research 33
-
- Hepatitis B Virus Studies 25
- Co-authors
- Gordon Y. C. CheungCuong VuongFrank R. DeLeoAndreas PeschelHwang‐Soo JooAmer E. VillaruzDaniel E. SturdevantBarry N. Kreiswirth
- Journals
- Antimicrobial Agents and Chemotherapy (28 papers)The Journal of Infectious Diseases (19 papers)Infection and Immunity (15 papers)
- Partner nations
- United StatesGermanyChina
In The Last Decade
Michaël Otto
374 papers receiving 38.6k citations
Hit Papers
Peers
Comparison fields: 5 of 183
- Microbiology 7.2k
- Infectious Diseases 19.7k
- Clinical Biochemistry 3.6k
- Molecular Medicine 1.8k
- Molecular Biology 23.2k
Countries citing papers authored by Michaël Otto
This map shows the geographic impact of Michaël Otto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michaël Otto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michaël Otto more than expected).
Fields of papers citing papers by Michaël Otto
This network shows the impact of papers produced by Michaël Otto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michaël Otto. The network helps show where Michaël Otto may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Michaël Otto, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | Staphylococcus aureus colonisation and strategies for decolonisationbreakdown → | 2024 | 55 |
| 3 | 2024 | 10 | |
| 4 | 2024 | 1 | |
| 5 | 2023 | 12 | |
| 6 | 2023 | 12 | |
| 7 | 2023 | 2 | |
| 8 | 2022 | 8 | |
| 9 | 2020 | 9 | |
| 10 | 2020 | 12 | |
| 11 | 2020 | 11 | |
| 12 | 2018 | 50 | |
| 13 | 2016 | 256 | |
| 14 | 2015 | 26 | |
| 15 | 2011 | 120 | |
| 16 | 2009 | 322 | |
| 17 | 2008 | 300 | |
| 18 | 2005 | 152 | |
| 19 | 2004 | 89 | |
| 20 | 2004 | 66 |
About Michaël Otto
Michaël Otto is a scholar working on Infectious Diseases, Microbiology and Virology, having authored 382 papers that have together received 39.6k indexed citations. Recurring topics across this work include Antimicrobial Resistance in Staphylococcus (200 papers), Bacterial biofilms and quorum sensing (166 papers), Antimicrobial Peptides and Activities (81 papers), Biochemical and Structural Characterization (60 papers), HIV/AIDS drug development and treatment (53 papers), Hepatitis C virus research (33 papers), Bacterial Identification and Susceptibility Testing (29 papers) and Hepatitis B Virus Studies (25 papers). The work is most often cited by research in Microbiology (7.2k citations), Infectious Diseases (19.7k citations) and Clinical Biochemistry (3.6k citations). Michaël Otto has collaborated with scholars based in United States, Germany and China. Frequent co-authors include Gordon Y. C. Cheung, Cuong Vuong, Frank R. DeLeo, Andreas Peschel, Hwang‐Soo Joo, Amer E. Villaruz, Daniel E. Sturdevant, Barry N. Kreiswirth, Henry F. Chambers and Friedrich Götz. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, The Journal of Infectious Diseases, Infection and Immunity, PLoS ONE and Antiviral chemistry & chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.